Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic

Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, Daniele Focosi
doi: https://doi.org/10.1101/2024.08.12.24311864

Article Information

doi 
https://doi.org/10.1101/2024.08.12.24311864
History 
  • August 12, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Massimo Franchini1,
  2. Arturo Casadevall2,
  3. Quigly Dragotakes2 and
  4. Daniele Focosi3,#
  1. 1Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy
  2. 2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, US
  3. 3North-Western Tuscany Blood Bank, Pisa University Hospital, Italy
  1. ↵#corresponding author : via Paradisa 2, 56124 Pisa, Italy. daniele.focosi{at}gmail.com.
Back to top
Posted August 12, 2024.
Download PDF
Data/Code
Email
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, Daniele Focosi
medRxiv 2024.08.12.24311864; doi: https://doi.org/10.1101/2024.08.12.24311864
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area